FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Novartis | vaccine research lab

Novartis blueprints $36M vaccine research lab in NC

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools
  • Subscribe
  • Email
  • Print
  • Contact Author
  • Reprint

Novartis ($NVS) has blueprinted plans for a $36 million vaccine research lab in Holly Springs, NC, and plans to fill about 100 high-paying jobs to staff the addition.

The expansion follows the construction of Novartis' $600 million vaccine manufacturing plant, which opened last year. This new facility will include vaccine manufacturing capacity to produce experimental vaccines for research studies.

Novartis, which landed a 167-acre site in Holly Springs, is creating a vaccine research and manufacturing hub in the area alongside Merck ($MRK) and Pfizer ($PFE).

- here's the story from the News & Observer

Related Articles:
Novartis vax division booms as demand spikes
N.C. town welcomes Novartis plant


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Novartis   vaccine research lab